Abstract
A hemoperfusion column containing anionic exchange resin coated with a new polymer has been tested in vivo for blood compatibility.
The hemocoagulative parameters, evaluated before and after the cartridge during hemoperfusion, did not show any significant alteration even as regards the number and the functionality of the platelets nor as regards a possible activation of the fibrinolysis process.
On the basis of these results, the hemoperfusion system examined can be regarded as hemocompatible from the hemocoagulative standpoint.
Get full access to this article
View all access options for this article.
